bifemelane   Click here for help

GtoPdb Ligand ID: 11742

Synonyms: Alnert® | BP-N-methylbutylamine | Celeport® | MCI-2016 | MCI2016
Approved drug
bifemelane is an approved drug (Japan only)
Compound class: Synthetic organic
Comment: Bifemelane acts as a monoamine oxidase inhibitor [1], with inhibitory activity against both MAO-A (competitive) and MAO-B (noncompetitive). It has nootropic, neuroprotective, and antidepressant effects in vivo.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 8
Topological polar surface area 21.26
Molecular weight 269.18
XLogP 4.02
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNCCCCOc1ccccc1Cc1ccccc1
Isomeric SMILES CNCCCCOc1ccccc1Cc1ccccc1
InChI InChI=1S/C18H23NO/c1-19-13-7-8-14-20-18-12-6-5-11-17(18)15-16-9-3-2-4-10-16/h2-6,9-12,19H,7-8,13-15H2,1H3
InChI Key QSQQPMHPCBLLGX-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Bifemelane is used clinically in Japan, to treat depressive symptoms in patients with either cerebral infarction or senile dementia.